CD19 and precursor B-cell acute lymphoblastic leukemia: Their results showed that only a small fraction of B-ALL cells, specifically those with a primitive CD34+/CD10−/CD19−/CD38− phenotype, were able to engraft B-ALL in NOD/SCID mice.